Lantheus Holdings (LNTH) Non-cash Items (2014 - 2025)

Lantheus Holdings (LNTH) reported Non-cash Items of $24.1 million for Q4 2025, up 7933.33% quarter-over-quarter from $300000.0 in Q4 2016.

Lantheus Holdings (LNTH) Non-cash Items (2014 - 2025) Analysis & Trends

Lantheus Holdings (LNTH) has 4 years of Non-cash Items data on file, last reported at $24.1 million in Q4 2025.

Non-cash Items for Q4 2025 came in at $24.1 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $24.1 million (changed N/A YoY), and the FY2025 annual result was $24.1 million, changed N/A from the prior year.
Non-cash Items advanced to $24.1 million in Q4 2025 per LNTH's latest filing, from $300000.0 in the prior quarter.
Over five years, Non-cash Items peaked at $24.1 million in Q4 2025 and troughed at $24.1 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn

Download Data